 SEATTLE, July 8, 2021 PRNewswire -- CTI BioPharma Corp. NASDAQ: CTIC today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Companys Amended and Restated 2017 Equity Incentive Plan but under the terms of the Amended and Restated 2017 Equity Incentive Plan and material to the employees acceptance of employment with the company. The equity award was approved on July 8, 2021, in accordance with Nasdaq Listing Rule 5635c4. 